Open

Study for Blood Cancer

In this study, we want to find out if a new study drug (ASTX727) is effective in treating blood cancer.

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Visit Availability

Standard business hours (M-F, 8-5)

Location

United States (Nationwide)

What will be asked of you

Subjects will have EKG, blood draws, physical exams, height and weight, vital signs, bone marrow and DNA swabs at certain visits.

Incentives

None

In-person visits:
6+

Total length of participation:
4+

Looking for Specific Volunteers

Able to participate:

You have a Diagnosis of Leukemia
At least 18 years of age
You have good liver, kidney, and heart function
You are able to swallow pills

Not eligible if:

You have a history of Brain Cancer
You have a history of Sickle Cell Anemia
You have a disease requiring IV therapy
You have an active infection

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Lineberger Comprehensive Cancer Center
cancerclinicaltrials@med.unc.edu
(919) 966-4432

Primary Visit Location

UNC Hospitals / UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Joshua Zeidner
LCCC - Clinical Trials

Study Type

Clinical or Medical
Interventional

Study Topics

Cancer (Leukemia)

IRB Number

23-1273

ClinicalTrials.gov

NCT05600894

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.